A Study to Evaluate the Relative Bioavailability of a Fixed-dose Combination Tablet of VX-121/Tezacaftor/Deutivacaftor
Clinical trial NCT05535959 · COMPLETED
Trial details
- NCT number
- NCT05535959
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-15
- Primary completion
- 2022-11-09
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.